• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 1275

6′-sialyllactose sodium salt

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants and formula for young children (>12 months) at a maximum level of 0.40 g/L and 0.5 g/L (as consumed), respectively, and in other food categories at maximum levels up to 125 g/L.
Basis: Scientific procedures
Notifier: Cataya Bio (Shanghai) Co., Ltd.
Notifier Address: Cataya Bio (Shanghai) Co., Ltd.
4th Floor of Building No. 2
No. 88 Darwin Road
Pudong New District
Shanghai 201203
CHINA
FDA's Letter: Pending
-
-